Group One Trading
SVA

Group One Trading’s Sinovac Biotech, Ltd SVA Stock Holding History

Group One Trading’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-33,600
Closed -$265K – 5760
2017
Q4 		$265K Buy
33,600
+3,500
+12% +$26.2K ﹤0.01% 2745
2017
Q3 		$212K Sell
30,100
-2,000
-6% -$13.7K ﹤0.01% 2724
2017
Q2 		$217K Buy
+32,100
New +$176K ﹤0.01% 2589
2017
Q1 		– Sell
-3,600
Closed -$21K – 5460
2016
Q4 		$21K Buy
+3,600
New +$21.7K ﹤0.01% 3695
2016
Q2 		– Sell
-400
Closed -$3K – 5396
2016
Q1 		$3K Hold
400
– – ﹤0.01% 4354
2015
Q4 		$2K Buy
+400
New +$2.15K ﹤0.01% 4582
2015
Q2 		– Sell
-15,200
Closed -$75K – 5670
2015
Q1 		$75K Hold
15,200
– – ﹤0.01% 3106
2014
Q4 		$80K Hold
15,200
– – ﹤0.01% 3032
2014
Q3 		$73K Sell
15,200
-5,900
-28% -$31.7K ﹤0.01% 3268
2014
Q2 		$119K Sell
21,100
-8,400
-28% -$51K ﹤0.01% 2822
2014
Q1 		$212K Sell
29,500
-3,500
-11% -$23.2K ﹤0.01% 2400
2013
Q4 		$202K Buy
33,000
+6,900
+26% +$41.6K ﹤0.01% 2422
2013
Q3 		$156K Buy
26,100
+7,200
+38% +$34.4K ﹤0.01% 2616
2013
Q2 		$74K Buy
+18,900
New +$70.3K ﹤0.01% 3099

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return

Group One Trading's SVA Position: Q3 2024 in Review

Group One Trading sold out of Sinovac Biotech, Ltd (SVA) in Q3 2024, closing a stake of 412 shares — an estimated $2.67K sold.

Group One Trading first reported a position in SVA in Q2 2013 and held it in 38 quarters. The position peaked at $220K in Q3 2017. 9 funds tracked by Wall St. Rank hold SVA as of Q3 2024.

  • Group One Trading reported no remaining Sinovac Biotech, Ltd position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 412 Sinovac Biotech, Ltd shares in Q3 2024, an estimated $2.67K.
  • Group One Trading first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 38 quarters.
  • Group One Trading's Sinovac Biotech, Ltd position peaked at $220K in Q3 2017.
  • 9 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.